No abstract available
Keywords:
androgen deprivation therapy; aromatase inhibitor; bisphosphonate; chronic kidney disease; denosumab; treatment gap.
MeSH terms
-
Aged
-
Androgen Antagonists
-
Bone Density
-
Bone Density Conservation Agents* / adverse effects
-
Breast Neoplasms*
-
Denosumab
-
Diphosphonates
-
Female
-
Humans
-
Longitudinal Studies
Substances
-
Denosumab
-
Bone Density Conservation Agents
-
Diphosphonates
-
Androgen Antagonists